TheraVet is a vet biotech company headquartered in Belgium (Jumet, Wallonia) with an US-based subsidiary.


TheraVet's mission is to develop innovative, safe and effective treatments to improve the well-being  and quality of life of companion animals suffering from osteoarticular diseases.


TheraVet's main targets (indications & applications) are osteoarthritis, ligament & tendon injuries and bone surgery in cats and dogs as well as horses.


TheraVet works in close collaboration with key opinion leaders in Belgium and abroad (France, Switzerland, United Kingdom & United States) to better address the ever-increasing needs of veterinary medicine.






TheraVet is committed to develop new treatments specifically adapted to pets.


The strong experience of the team ensures a rigorous development process addressing the current market and regulatory trends.

This website uses cookies The website of TheraVet SA uses functional cookies. In case of analysing our traffic or advertising, we also place cookies that share information about your use of our site with our analytics partners, our social media and advertising partners, who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.
Show details Hide details
Allow selection Allow all cookies